HomeANNX • STO
add
Annexin Pharmaceuticals AB (publ)
Previous close
kr 0.27
Day range
kr 0.27 - kr 0.28
Year range
kr 0.18 - kr 0.75
Market cap
94.96M SEK
Avg Volume
229.37K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.46M | 24.20% |
Net income | -12.46M | -23.33% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -12.41M | -24.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.87M | -61.51% |
Total assets | 11.81M | -51.67% |
Total liabilities | 5.47M | 24.34% |
Total equity | 6.34M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -161.47% | — |
Return on capital | -247.57% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -12.46M | -23.33% |
Cash from operations | -13.54M | -16.24% |
Cash from investing | — | — |
Cash from financing | -10.00K | -101.14% |
Net change in cash | -13.54M | -26.97% |
Free cash flow | -8.91M | -14.08% |
About
Founded
2014
Website
Employees
4
